Montenegro Residency, February 14: €150K Property Threshold Sparks Exit
Montenegro residency by invest: €150,000 property threshold and €5,000 tax floor from 17 Jan 2026. What German investors should know, risks, and next steps.
Get the latest Government & Law news in the US, UK & Australia. MEYKA AI delivers fast, reliable updates on policies, court rulings & regulations.
Montenegro residency by invest: €150,000 property threshold and €5,000 tax floor from 17 Jan 2026. What German investors should know, risks, and next steps.
Marco Rubio MSC speech pushes Europe on defense and Russia oil sanctions. What it means for German investors in defense and energy, with key dates, risks, and signals to watch next week.
Peter Murrell indictment over alleged £459,000 SNP embezzlement sharpens focus on party finances, Holyrood vote timing, and GBP risk. Key facts, timelines, and what investors should watch next.
The Paul Caneiro verdict spotlights arson claims, insurance fraud risk, and small business governance, with clear implications for U.S. insurers, policyholders, and investors seeking clarity on loss,,
Singapore measles cases febury reach 13 YTD on Feb 15. CDA tightens isolation and contact tracing, with up to 21-day quarantine. What investors and employers in Singapore should do now.
Emmanuel Macron’s stance at the Munich Security Conference exposes a France‑Germany split on Europe’s defense. What this means for NATO, EU spending, and German investors.
CAAT Pension Plan faces an FSRA examination after CEO Derek Dobson was put on leave following whistleblower claims. Funding remains intact. What it means for Canadians.
palestine action ban highcourt ruling shifts UK protest risk. High Court finds proscription disproportionate, pending appeal. What it means for Elbit Systems UK and ESLT stock today.
Fukui Prefecture harassment Or draft follows recognition of former governor sexual harassment. We explain impacts on public sector compliance in Japan, procurement risk, and ESG.
Shingrix Germany coverage expands today for high‑risk adults 18+, with standard use for 60+. What this reimbursement decision means for GSK stock, demand, and timelines.